Sanofi

SARCLISA

  1. Home
  2.  / 
  3. J Code
  4.  / SARCLISA – J9227

Manufacturer:

Sanofi

Name:

SARCLISA

HCPCS Code Descriptor:

Injection, isatuximab-irfc, 10 mg

Category:

J Code

HCPCS:

J9227

NDC(s):

00024-0654-01, 00024-0656-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

SARCLISA is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J9227 is aligned to the drug SARCLISA.

Access Pricing and More By Registering

HCPCS Added Date:

10/1/20

HCPCS Effective Date:

10/1/20

HCPCS Short Description:

Inj. isatuximab-irfc 10 mg

Billing and Coding Guide:

https://www.sarclisahcp.com/assets/pdfs/SARCLISA_Billing_and_Coding_Guide_MAT-US-2102121-v2.pdf

Patient Assistance:

https://www.sanoficareassist.com/

SARCLISA - J9227